InvestorsHub Logo
Followers 11
Posts 834
Boards Moderated 0
Alias Born 02/19/2014

Re: H2R post# 45170

Tuesday, 11/17/2015 2:14:20 PM

Tuesday, November 17, 2015 2:14:20 PM

Post# of 709714
I second that great find Asta,

Also let us not forget what recently happened to the CLDX GBM trial and the FDA rebuttal of OS use for AA in a small population trial.

Good thing we track both PFS and OS and we already enlarged our trial. It would seem that from the perspective of the trial design ours is quite formidable.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News